Cargando…
Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign hae...
Autores principales: | Malabu, Usman Hammawa, Karamatic, Rozemary, Mahy, Gillian, Sangla, Kunwarjit Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420657/ https://www.ncbi.nlm.nih.gov/pubmed/22937281 http://dx.doi.org/10.1155/2011/342480 |
Ejemplares similares
-
Calcific Uremic Arteriolopathy on Multimodal Combination Therapy: Still Unmet Goal
por: Malabu, Usman Hammawa, et al.
Publicado: (2012) -
Bilateral adrenal gland haemorrhage: an unusual cause
por: Gowda, Durgesh, et al.
Publicado: (2014) -
Influence of Ethnicity on Outcomes of Diabetes Inpatient Hypoglycemia: an Australian Perspective
por: Malabu, Usman H, et al.
Publicado: (2020) -
Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo-controlled, single-center study
por: Vangaveti, Venkat N., et al.
Publicado: (2022) -
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours
por: Korse, C M, et al.
Publicado: (2011)